CG Oncology reported revenue of $1.16M and net income of -$79.10M for the quarter ended Jun 2026. This income statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 3.86M | 4.04M | 5.07M | 4.33M | 47.06M | 66.66M | 67.54M | 62.50M | 76.22M | 76.23M | 78.28M | 80.69M | 88.01M | 88.31M |
| Revenue & cost | ||||||||||||||
| Revenue | 0.19M | 0.01M | 0.00M | 0.53M | 0.11M | 0.04M | 0.46M | 0.05M | 1.67M | 2.32M | 1.08M | 1.16M | ||
| Gross Profit | 0.04M | 0.46M | 0.05M | 0.09M | -0.75M | -1.88M | -2.77M | |||||||
| Operating items | ||||||||||||||
| Research & DevelopmentR&D | 7.84M | 9.83M | 11.73M | 16.34M | 17.21M | 18.47M | 19.62M | 26.80M | 27.47M | 31.33M | 27.88M | 29.96M | 43.73M | 54.66M |
| Selling, General & AdministrativeSG&A | 2.07M | 2.49M | 2.32M | 3.02M | 5.79M | 7.49M | 8.72M | 11.71M | 14.79M | 17.41M | 23.33M | 17.99M | 20.78M | 28.98M |
| Other Operating ExpensesOther Opex | 1.58M | 3.07M | 2.96M | 3.92M | ||||||||||
| Operating ExpensesOpex | 9.91M | 12.33M | 14.05M | 19.36M | 23.00M | 25.96M | 28.34M | 38.51M | 42.26M | 48.74M | 52.80M | 51.02M | 67.47M | 87.56M |
| Operating IncomeOp. Inc | -9.72M | -12.33M | -14.04M | -19.36M | -22.47M | -25.85M | -28.30M | -38.05M | -42.20M | -48.74M | -51.13M | -48.70M | -66.39M | -86.40M |
| EBIT | -9.72M | -12.33M | -14.04M | -19.36M | -22.47M | -25.85M | -28.30M | -38.05M | -42.20M | -48.74M | -51.13M | -48.70M | -66.39M | -86.40M |
| Non-operating items | ||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 1.05M | 0.77M | 2.28M | 2.80M | 5.54M | 6.94M | 7.89M | 6.25M | 7.75M | 7.32M | 7.42M | 7.44M | 6.29M | 7.33M |
| Other Non Operating IncomeOther Non Op Inc. | 0.01M | -0.06M | -0.01M | -0.00M | -0.01M | 0.01M | -0.00M | 0.01M | 0.01M | -0.00M | -0.10M | -0.05M | -0.10M | 0.02M |
| Non Operating IncomeNon Op. Inc. | 1.05M | 0.71M | 2.27M | 2.80M | 5.54M | 6.95M | 7.89M | 6.25M | 7.75M | 7.32M | 7.32M | 7.39M | 6.19M | 7.34M |
| Net income details | ||||||||||||||
| EBT | -8.68M | -11.55M | -11.76M | -16.55M | -16.93M | -18.91M | -20.40M | -31.80M | -34.46M | -41.42M | -43.71M | -41.26M | -60.10M | -79.07M |
| Profit After TaxPAT | -8.67M | -11.61M | -11.77M | -16.55M | -16.93M | -18.90M | -20.41M | -31.80M | -34.45M | -41.43M | -43.81M | -41.30M | -60.20M | -79.10M |
| Income from Continuing OperationsIncome (Continuing) | -8.68M | -11.55M | -11.76M | -16.55M | -16.93M | -18.91M | -20.40M | -31.80M | -34.46M | -41.42M | -43.71M | -41.26M | -60.10M | -79.07M |
| Consolidated Net IncomeConsol Net Inc. | -8.68M | -11.55M | -11.76M | -16.55M | -16.93M | -18.91M | -20.40M | -31.80M | -34.46M | -41.42M | -43.71M | -41.26M | -60.10M | -79.07M |
| Income towards Parent CompanyParent Net Inc | -8.68M | -11.55M | -11.76M | -16.55M | -16.93M | -18.91M | -20.40M | -31.80M | -34.46M | -41.42M | -43.71M | -41.26M | -60.10M | -79.07M |
| Preferred Dividend PaymentsPref Dividends | 3.73M | 3.78M | 5.34M | 5.93M | ||||||||||
| Net Income towards Common StockholdersNet Income | -12.40M | -15.39M | -17.51M | -22.49M | -16.93M | -18.90M | -20.41M | -31.80M | -34.46M | -41.42M | -43.71M | -41.26M | -60.10M | -79.07M |
| Additional items | ||||||||||||||
| EPS (Basic) | -3.22 | -3.93 | -4.00 | -5.19 | -0.36 | -0.28 | -0.30 | -0.51 | -0.45 | -0.54 | -0.57 | -0.53 | -0.71 | -0.90 |
| EPS (Diluted) | -3.22 | -3.93 | -4.00 | -5.19 | -0.36 | -0.28 | -0.30 | -0.51 | -0.45 | -0.54 | -0.57 | -0.53 | -0.71 | -0.90 |
| Shares Outstanding | 3.86M | 3.92M | 4.38M | 4.33M | 47.06M | 66.65M | 67.14M | 62.50M | 76.19M | 76.23M | 76.73M | 77.30M | 84.52M | 88.20M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 3.86M | 3.92M | 4.38M | 4.33M | 47.06M | 66.65M | 67.14M | 62.50M | 76.19M | 76.23M | 76.73M | 77.30M | 84.52M | 88.20M |
| EBITDA | -9.72M | -12.33M | -14.04M | -19.36M | -22.47M | -25.85M | -28.30M | -38.05M | -42.20M | -48.74M | -51.13M | -48.70M | -66.39M | -86.40M |